Accession Number:

ADA460291

Title:

Randomized Trial of Neuroprotective Effects of Erythropoietin in Patients Receiving Adjuvant Chemotherapy for Breast Cancer: Position Emission Tomography and NE

Descriptive Note:

Final rept. 1 Oct 2002-31 Aug 2006

Corporate Author:

WEST VIRGINIA UNIV RESEARCH CORP MORGANTOWN

Personal Author(s):

Report Date:

2006-09-01

Pagination or Media Count:

7.0

Abstract:

Adjuvant treatment with Adriamycin and cyclophosphamide AC clearly prolongs the overall survival in women with breast cancer. Cognitive deficits e.g. problems with memory and concentration are common during and after adjuvant breast cancer chemotherapy, but the pathophysiology of cognitive phenomens is unknown. The goal of this project is to study the pathophysiology of cognitive dysfunction in patients receiving adjuvant treatment using Positron Emission Tomography PET scan.

Subject Categories:

  • Biochemistry
  • Anatomy and Physiology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE